STERIS plc

NYSE:STE Stock Report

Market Cap: US$20.7b

STERIS Management

Management criteria checks 3/4

STERIS' CEO is Dan Carestio, appointed in Jul 2021, has a tenure of 3.42 years. total yearly compensation is $9.55M, comprised of 10.8% salary and 89.2% bonuses, including company stock and options. directly owns 0.057% of the company’s shares, worth $11.77M. The average tenure of the management team and the board of directors is 4.9 years and 7.8 years respectively.

Key information

Dan Carestio

Chief executive officer

US$9.6m

Total compensation

CEO salary percentage10.8%
CEO tenure3.4yrs
CEO ownership0.06%
Management average tenure4.9yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Dec 14
STERIS plc's (NYSE:STE) Popularity With Investors Is Clear

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Nov 18

What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Oct 19
What Does STERIS plc's (NYSE:STE) Share Price Indicate?

Is STERIS (NYSE:STE) A Risky Investment?

Oct 01
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued

Sep 16

Earnings Tell The Story For STERIS plc (NYSE:STE)

Sep 13
Earnings Tell The Story For STERIS plc (NYSE:STE)

Steris: Q2 Numbers Solidify Buy Thesis

Aug 13

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

Aug 08
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price

When Should You Buy STERIS plc (NYSE:STE)?

Jul 04
When Should You Buy STERIS plc (NYSE:STE)?

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

Steris declares $0.47 dividend

Nov 02

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

CEO Compensation Analysis

How has Dan Carestio's remuneration changed compared to STERIS's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$591m

Jun 30 2024n/an/a

US$561m

Mar 31 2024US$10mUS$1m

US$551m

Dec 31 2023n/an/a

US$1b

Sep 30 2023n/an/a

US$1b

Jun 30 2023n/an/a

US$576m

Mar 31 2023US$8mUS$970k

US$557m

Dec 31 2022n/an/a

-US$28m

Sep 30 2022n/an/a

-US$8m

Jun 30 2022n/an/a

US$377m

Mar 31 2022US$6mUS$767k

US$285m

Dec 31 2021n/an/a

US$279m

Sep 30 2021n/an/a

US$250m

Jun 30 2021n/an/a

US$286m

Mar 31 2021US$3mUS$542k

US$397m

Dec 31 2020n/an/a

US$433m

Sep 30 2020n/an/a

US$424m

Jun 30 2020n/an/a

US$413m

Mar 31 2020US$2mUS$522k

US$408m

Dec 31 2019n/an/a

US$393m

Sep 30 2019n/an/a

US$336m

Jun 30 2019n/an/a

US$319m

Mar 31 2019US$2mUS$482k

US$304m

Dec 31 2018n/an/a

US$269m

Sep 30 2018n/an/a

US$316m

Jun 30 2018n/an/a

US$303m

Mar 31 2018US$1mUS$379k

US$291m

Compensation vs Market: Dan's total compensation ($USD9.55M) is about average for companies of similar size in the US market ($USD12.63M).

Compensation vs Earnings: Dan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Dan Carestio (51 yo)

3.4yrs

Tenure

US$9,550,776

Compensation

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...

Leadership Team

NamePositionTenureCompensationOwnership
Daniel Carestio
President3.4yrsUS$9.55m0.057%
$ 11.8m
Michael Tokich
Senior VP & CFO16.8yrsUS$3.24m0.047%
$ 9.7m
John Zangerle
Senior VP11.4yrsUS$2.63m0.034%
$ 7.0m
Mary Fraser
SVP & Chief Human Resources Officer4.4yrsUS$1.85m0.011%
$ 2.3m
Cary Majors
Senior VP & President of Healthcare5.3yrsUS$2.15m0.012%
$ 2.4m
Karen Burton
VP & Chief Accounting Officer7.9yrsno data0.0044%
$ 914.1k
Julie Winter
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Julia Madsen
Senior VP & GM of Life Sciences4.4yrsno data0.0095%
$ 2.0m
Andrew Xilas
Senior VP & GM of Dental3.5yrsUS$1.92m0.0064%
$ 1.3m
Kenneth Kohler
Senior VP & GM of ASTno datano data0.0035%
$ 730.0k
Renato Tamaro
VP & Corporate Treasurer7.3yrsno data0.0069%
$ 1.4m
Walter Rosebrough
CEO Emeritus & Senior Advisor3.4yrsUS$1.16mno data

4.9yrs

Average Tenure

56yo

Average Age

Experienced Management: STE's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Daniel Carestio
President3.9yrsUS$9.55m0.057%
$ 11.8m
Richard Breeden
Independent Director16.7yrsUS$353.94k0.033%
$ 6.8m
Mohsen Sohi
Independent Chairman of the Board19.4yrsUS$503.73k0.023%
$ 4.7m
Jacqueline Kosecoff
Independent Director21.2yrsUS$348.93k0.027%
$ 5.6m
Cynthia Feldmann
Independent Director19.8yrsUS$349.84k0.0095%
$ 2.0m
Richard Steeves
Independent Director9.1yrsUS$349.96k0%
$ 0
Paul Martin
Independent Director3.6yrsUS$342.28kno data
Nirav Shah
Independent Director6.6yrsUS$336.34k0.00030%
$ 62.0k
Christopher Holland
Independent Director4.4yrsUS$342.34k0.00059%
$ 122.0k
Esther Alegria
Independent Director1.6yrsUS$408.96kno data

7.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: STE's board of directors are considered experienced (7.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 23:05
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

STERIS plc is covered by 25 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Michael PolarkBaird
Erin Wilson WrightBofA Global Research